Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PJP vs. GGHCX: which is better?

Bottom line

PJP vs GGHCX: the short answer

PJP (Invesco Pharmaceuticals ETF) and GGHCX (INVESCO Health Care Fund) are quite different portfolios: only about 36% of their top holdings (by weight) are shared.

But GGHCX is far broader, holding 82 positions to 33 for PJP, so beyond the top names it adds exposure PJP doesn't have.

PJP is cheaper at 0.58% vs 1.07% — a difference of $49 a year per $10,000 invested.

Over five years, PJP returned +9.0% a year vs +2.6% for GGHCX.

GGHCX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

PJP vs GGHCX side by side

PJPGGHCX
TypeETFMutual fund
Fund familyInvescoInvesco
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.58%1.07%
Annual cost per $10k$58$107
10-yr cost on $10k (prospectus)$726$1,784
Max front loadNone5.5%
12b-1 fee—0.25%
1-yr return+27.9%+9.2%
5-yr return (annualized)+9.0%+2.6%
10-yr return (annualized)+5.1%+5.8%
Best quarter+18.1%+19.6%
Worst quarter−14.8%−16.5%
Net assets (fund)$472.1M$1.2B
Number of holdings3382
Portfolio turnover36%59%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPJPGGHCXDifference
2025+27.9%+15.5%+12.4%
2024+9.7%+4.0%+5.7%
2023−2.2%+3.1%−5.3%
2022−2.0%−13.5%+11.5%
2021+14.5%+12.2%+2.3%
2020+11.2%+14.5%−3.3%
2019+4.7%+32.0%−27.3%
2018−1.7%+0.5%−2.2%
2017+15.3%+15.5%−0.1%
2016−19.3%−11.7%−7.5%

Source: Fund prospectus bar charts

Holdings overlap

8 of PJP's top 25 holdings also appear in GGHCX's top 25.

Shared top holdings
HoldingPJPGGHCX
Invesco Private Prime Fund7.93%4.67%
AbbVie Inc.5.48%4.03%
Johnson & Johnson5.18%6.76%
Merck & Co., Inc.5.06%4.59%
Eli Lilly and Co.5.02%10.59%
Gilead Sciences, Inc.4.53%3.63%
Invesco Private Government Fund3.73%1.80%
Ligand Pharmaceuticals Inc.3.20%1.18%

Source: SEC Form N-PORT

PJP top 10

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. AbbVie Inc. — 5.48%
  4. Amgen Inc. — 5.33%
  5. Johnson & Johnson — 5.18%
  6. Merck & Co., Inc. — 5.06%
  7. Eli Lilly and Co. — 5.02%
  8. Corcept Therapeutics Inc. — 4.96%
  9. Gilead Sciences, Inc. — 4.53%
  10. Pfizer Inc. — 4.50%

GGHCX top 10

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. AbbVie Inc. — 4.03%
  7. Gilead Sciences, Inc. — 3.63%
  8. argenx SE — 3.24%
  9. CVS Health Corp. — 2.52%
  10. Welltower Inc. — 2.34%

FAQ

What is the difference between PJP and GGHCX?
PJP (Invesco Pharmaceuticals ETF) and GGHCX (INVESCO Health Care Fund) are quite different portfolios: only about 36% of their top holdings (by weight) are shared. But GGHCX is far broader, holding 82 positions to 33 for PJP, so beyond the top names it adds exposure PJP doesn't have.
Which is cheaper, PJP or GGHCX?
PJP has the lower expense ratio (0.58%).
Should I own both PJP and GGHCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.